EP0822815A4 - Verfahren zur oralen bioverfügbarkeitmachung pharmazeutisch aktiver taxane - Google Patents

Verfahren zur oralen bioverfügbarkeitmachung pharmazeutisch aktiver taxane

Info

Publication number
EP0822815A4
EP0822815A4 EP97901977A EP97901977A EP0822815A4 EP 0822815 A4 EP0822815 A4 EP 0822815A4 EP 97901977 A EP97901977 A EP 97901977A EP 97901977 A EP97901977 A EP 97901977A EP 0822815 A4 EP0822815 A4 EP 0822815A4
Authority
EP
European Patent Office
Prior art keywords
pharmaceutically active
orally bioavailable
making pharmaceutically
active taxanes
taxanes orally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP97901977A
Other languages
English (en)
French (fr)
Other versions
EP0822815A1 (de
Inventor
Steven B Hansel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of EP0822815A1 publication Critical patent/EP0822815A1/de
Publication of EP0822815A4 publication Critical patent/EP0822815A4/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP97901977A 1996-01-31 1997-01-15 Verfahren zur oralen bioverfügbarkeitmachung pharmazeutisch aktiver taxane Ceased EP0822815A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1091696P 1996-01-31 1996-01-31
US10916P 1996-01-31
PCT/US1997/000405 WO1997027855A1 (en) 1996-01-31 1997-01-15 A method of making pharmaceutically active taxanes orally bioavailable

Publications (2)

Publication Number Publication Date
EP0822815A1 EP0822815A1 (de) 1998-02-11
EP0822815A4 true EP0822815A4 (de) 1998-04-01

Family

ID=21748017

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97901977A Ceased EP0822815A4 (de) 1996-01-31 1997-01-15 Verfahren zur oralen bioverfügbarkeitmachung pharmazeutisch aktiver taxane

Country Status (3)

Country Link
EP (1) EP0822815A4 (de)
CA (1) CA2221444A1 (de)
WO (1) WO1997027855A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245805B1 (en) 1995-10-26 2001-06-12 Baker Norton Pharmaceuticals, Inc. Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
US6395770B1 (en) 1995-10-26 2002-05-28 Baker Norton Pharmaceuticals, Inc. Method and compositions for administering taxanes orally to human patients
PL337064A1 (en) * 1997-05-27 2000-07-31 Baker Norton Pharma Method of and compositions for orally administering taxanes to human beings
BR0015149A (pt) * 1999-10-27 2002-10-29 Baker Norton Pharma Método e composições para administração de taxanos oralmente a pacientes humanos
KR20020013174A (ko) * 2000-08-11 2002-02-20 민경윤 경구 흡수율이 낮은 약물의 흡수율을 증가시키기 위한경구용 조성물
DE60220519T2 (de) 2001-04-20 2007-09-27 The University Of British Columbia, Vancouver Mizellares arzneistoffverabreichungssystem für hydrophobe arzneistoffe

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014467A1 (fr) * 1991-02-25 1992-09-03 Debiopharm S.A. Agents therapeutiques pour le traitement de la resistance multidrogue de cancers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2129288C (en) * 1993-08-17 2000-05-16 Jerzy Golik Phosphonooxymethyl esters of taxane derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014467A1 (fr) * 1991-02-25 1992-09-03 Debiopharm S.A. Agents therapeutiques pour le traitement de la resistance multidrogue de cancers

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LUM ET AL.: "MDR expression in normal tissues : pharmacologic implications for the clinical use of P-glycoprotein inhibitors.", DRUG RESISTANCE IN CLINICAL ONCOLOGY AND HAEMATOLOGY, vol. 9, no. 2, - 1995, pages 319 - 336, XP009055111 *
See also references of WO9727855A1 *

Also Published As

Publication number Publication date
AU1575897A (en) 1997-08-22
EP0822815A1 (de) 1998-02-11
WO1997027855A1 (en) 1997-08-07
CA2221444A1 (en) 1997-08-07
AU701607B2 (en) 1999-02-04

Similar Documents

Publication Publication Date Title
ZA968767B (en) Pharmaceutically active compounds
AU1325001A (en) Methods of making a superconductor
SG80101A1 (en) Method of producing a contact structure
HUP9900143A3 (en) Pharmaceutically useful 3-pyridil-compounds
EP0822815A4 (de) Verfahren zur oralen bioverfügbarkeitmachung pharmazeutisch aktiver taxane
AU1368600A (en) A method of forming a superconductor
GB9526511D0 (en) Pharmaceutically active compounds
GB2319772B (en) 2-phenylazulene derivatives and a manufacturing method of these compounds
GB9821967D0 (en) Process for the preparation of orally active cephalosporin antibiotic-cefixim
GB9821966D0 (en) Process for the preparation of orally active cephalosporin antibiotic-cefixim
GB9502668D0 (en) Pharmaceutically active compounds
GB9506274D0 (en) Pharmaceutically active compounds
GB9502541D0 (en) Pharmaceutically active compounds
GB9502429D0 (en) Pharmaceutically active compounds
GB9521231D0 (en) Pharmaceutically active compounds
GB9518486D0 (en) Pharmaceutically active compounds
GB9518039D0 (en) Pharmaceutically active compounds
GB9515884D0 (en) Pharmaceutically active compounds
GB9505076D0 (en) Pharmaceutically active compounds
GB9500427D0 (en) Pharmaceutically active compounds
GB9510468D0 (en) Pharmaceutically active compounds
GB9513686D0 (en) Pharmaceutically active compounds
GB9510461D0 (en) Pharmaceutically active compounds
GB9510406D0 (en) Pharmaceutically active compounds
GB9509942D0 (en) Pharmaceutically active compounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19971117

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RHK1 Main classification (correction)

Ipc: A61K 31/49

A4 Supplementary search report drawn up and despatched

Effective date: 19980216

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 19980529

TPAD Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOS TIPA

TPAD Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOS TIPA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20020218